Atrás
Rango del Día
$127.40
$130.60
Rango de 52 Semanas
$107.00
$160.29
Volumen
247,294
Promedio 50D / 200D
$145.75
/
$134.64
Cierre Anterior
$129.93
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 4364.7 | 0.4 |
| P/B | 1.5 | 2.9 |
| ROE % | 0.0 | 3.7 |
| Net Margin % | 0.0 | 3.9 |
| Rev Growth 5Y % | 14.1 | 10.0 |
| D/E | 0.7 | 0.2 |
Precio Objetivo de Analistas
Hold
$179.00
+38.3%
Low: $178.00
High: $180.00
P/E Futuro
16.0
EPS Futuro
$8.10
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
2.2 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$11.09
$10.92 – $11.28
|
2.4 B | 1 |
| FY2029 |
$10.50
$10.34 – $10.68
|
2.3 B | 1 |
| FY2028 |
$10.19
$9.27 – $11.10
|
2.3 B | 2 |
Puntos Clave
Revenue grew 14.09% annually over 5 years — strong growth
ROE of 0.04% is below average
Generating 91.80M in free cash flow
P/E of 4364.65 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 20.47%
Cash machine — converts 12541.53% of earnings into free cash flow
Crecimiento
Revenue Growth (5Y)
14.09%
Revenue (1Y)-6.38%
Earnings (1Y)N/A
FCF Growth (3Y)12.50%
Calidad
Return on Equity
0.04%
ROIC2.28%
Net Margin0.03%
Op. Margin4.80%
Seguridad
Debt / Equity
0.66
Current Ratio2.36
Interest Coverage1.01
Valoración
P/E Ratio
4364.65
P/B Ratio1.50
EV/EBITDA40.01
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6.38% | Revenue Growth (3Y) | -0.65% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 14.09% | Earnings Growth (5Y) | -70.97% |
| Profitability | |||
| Revenue (TTM) | 2.23B | Net Income (TTM) | 732,000.0 |
| ROE | 0.04% | ROA | 0.02% |
| Gross Margin | 36.76% | Operating Margin | 4.80% |
| Net Margin | 0.03% | Free Cash Flow (TTM) | 91.80M |
| ROIC | 2.28% | FCF Growth (3Y) | 12.50% |
| Safety | |||
| Debt / Equity | 0.66 | Current Ratio | 2.36 |
| Interest Coverage | 1.01 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 4364.65 | P/B Ratio | 1.50 |
| P/S Ratio | 1.43 | PEG Ratio | -47.73 |
| EV/EBITDA | 40.01 | Dividend Yield | 0.00% |
| Market Cap | 3.19B | Enterprise Value | 4.28B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.23B | 2.38B | 2.26B | 2.28B | 1.32B |
| Net Income | 732,000.0 | -117.69M | -29.66M | -74.29M | 103.14M |
| EPS (Diluted) | 0.03 | -4.83 | -1.23 | -3.11 | 4.74 |
| Gross Profit | 819.66M | 824.78M | 739.87M | 697.76M | 491.49M |
| Operating Income | 106.95M | 42.96M | 22.83M | -42.90M | 123.25M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4.05B | 4.20B | 4.38B | 4.52B | 1.88B |
| Total Liabilities | 1.93B | 2.24B | 2.26B | 2.43B | 264.71M |
| Shareholders' Equity | 2.12B | 1.97B | 2.12B | 2.09B | 1.62B |
| Total Debt | 1.39B | 1.64B | 1.70B | 1.73B | 45.05M |
| Cash & Equivalents | 307.96M | 308.57M | 254.22M | 208.78M | 552.83M |
| Current Assets | 1.18B | 1.44B | 1.22B | 1.24B | 1.03B |
| Current Liabilities | 498.86M | 556.18M | 481.84M | 494.56M | 200.78M |